ABSTRACT
In a severe pandemic, rapid production and deployment of vaccines will potentially be critical in mitigating the impact on populations and essential services. We compared access to vaccines and timing of delivery relative to identification of A(H1N1)pdm09 and the geographic progression of the pandemic in the WHO European Region in order to identify gaps in provision. Information on vaccine procurement and donations was collected through a web-based survey conducted in all 53 member states of the Region. Among the 51 countries responding to the survey, the majority (84%) implemented vaccination campaigns against A(H1N1)pdm09. However, time of vaccine receipt and number of doses varied substantially across the region, with delayed access in many countries especially in those in the lowest income range. Improving access to influenza vaccines in low resource countries and solving issues of product liability should help reduce inequalities and operational challenges arising during a future public health crisis.
Subject(s)
Healthcare Disparities/statistics & numerical data , Influenza A Virus, H1N1 Subtype/pathogenicity , Influenza Vaccines , Influenza, Human/epidemiology , Vaccination/statistics & numerical data , Data Collection , Europe/epidemiology , Humans , Immunization Programs/organization & administration , Influenza, Human/virologyABSTRACT
ЕРБ ВОЗ разработало модель и инструмент с целью оказания помощи странам в разработке их собственной национальной оценки ответных действий против пандемии. Дополняет инструмент, разработанный ECDC. Обновлено в апреле 2011 г.
Subject(s)
Civil Defense , National Health Programs , Pandemics , Epidemiological MonitoringABSTRACT
WHO/Europe has developed a framework and a tool for countries to perform their own national evaluation of the pandemic response. It complements a tool developed by the ECDC. Updated April 2011.
Subject(s)
National Health Programs , Pandemics , Epidemiological Monitoring , Civil DefenseABSTRACT
Цель этого документа заключается в том, чтобы четко разъяснить государствамчленам, национальным лабораториям по диагностике гриппа и учреждениям, признаннымВОЗ в качестве Национальных центров по гриппу, процедуру процесса признанияНационального центра по гриппу (НЦГ) со стороны ВОЗ1 . Признание на уровне ВОЗ - этоформальное подтверждение того, что национальная лаборатория по гриппу соответствуеткругу ведения НЦГ ВОЗ.2
Subject(s)
Influenza, Human , Influenza Vaccines , Laboratories , Guideline , World Health OrganizationABSTRACT
The purpose of this document is to clarify to Member States, to national influenza laboratories and to institutions recognized by WHO as National Influenza Centres (NICs) the process of obtaining and maintaining WHO recognition as a National Influenza Centre (NIC). Recognition by WHO is the formal acknowledgment that the national influenza laboratory complies with the WHO NIC terms of reference (ToR).
